𝔖 Bobbio Scriptorium
✦   LIBER   ✦

SMAD4 is a predictive marker for 5-fluorouracil-based chemotherapy in patients with colorectal cancer

✍ Scribed by Boulay, J-L; Mild, G; Lowy, A; Reuter, J; Lagrange, M; Terracciano, L; Laffer, U; Herrmann, R; Rochlitz, C

Book ID
109997350
Publisher
Nature Publishing Group
Year
2002
Tongue
English
Weight
112 KB
Volume
87
Category
Article
ISSN
0007-0920

No coin nor oath required. For personal study only.

πŸ“œ SIMILAR VOLUMES

SMAD7 is a prognostic marker in patients
SMAD7 is a prognostic marker in patients with colorectal cancer
✍ Jean-Louis Boulay; Gabriele Mild; Adam Lowy; Juergen Reuter; Magali Lagrange; Lu πŸ“‚ Article πŸ“… 2003 πŸ› John Wiley and Sons 🌐 French βš– 82 KB

## Abstract Chromosomal region 18q21 is frequently deleted in colorectal cancer (CRC) and is associated with poor prognosis. Potential tumor suppressor mechanisms altered by 18q21 deletion include mediation of TGFΞ² signaling by SMADs. Following the definition of __SMAD4__ deletion as a negative pre

A Bayesian method for predicting 5-fluor
A Bayesian method for predicting 5-fluorouracil pharmacokinetic parameters following short-term infusion in patients with colorectal cancer
✍ M. Climente-MartΓ­; M. Merino-SanjuΓ‘n; D. Almenar-Cubells; N.V. JimΓ©nez-Torres πŸ“‚ Article πŸ“… 2003 πŸ› John Wiley and Sons 🌐 English βš– 136 KB

The objective of this study was to develop a population pharmacokinetic model and validate it using a Bayesian approach for predicting, a priori and a posteriori, the individual volume of distribution (V(d)) and clearance (Cl) of 5-fluorouracil (5-FU) given as short-term intravenous infusion in week